Insider Selling: Danaher (NYSE:DHR) EVP Sells 1,320 Shares of Stock

Danaher Corporation (NYSE:DHR) EVP Gregory Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Danaher Stock Down 0.8%

Shares of NYSE DHR traded down $1.69 during mid-day trading on Friday, reaching $209.56. 4,471,031 shares of the company’s stock traded hands, compared to its average volume of 4,283,277. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The business has a 50-day simple moving average of $227.19 and a 200 day simple moving average of $215.69. The stock has a market cap of $148.02 billion, a P/E ratio of 41.58, a PEG ratio of 2.82 and a beta of 0.91. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.14 earnings per share. On average, analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio is 25.40%.

Institutional Investors Weigh In On Danaher

A number of institutional investors and hedge funds have recently bought and sold shares of DHR. Cambient Family Office LLC bought a new position in shares of Danaher during the 4th quarter valued at about $4,011,000. McLaughlin Asset Management Inc. purchased a new stake in Danaher in the fourth quarter worth approximately $495,000. Wick Capital Partners LLC bought a new position in Danaher during the fourth quarter valued at approximately $761,000. Compound Planning Inc. raised its stake in shares of Danaher by 47.1% during the fourth quarter. Compound Planning Inc. now owns 9,554 shares of the conglomerate’s stock worth $2,187,000 after acquiring an additional 3,060 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of Danaher by 8.1% in the 4th quarter. Invesco Ltd. now owns 4,120,223 shares of the conglomerate’s stock worth $943,201,000 after acquiring an additional 307,095 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on DHR shares. TD Cowen restated a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Jefferies Financial Group upped their price objective on Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. HSBC increased their price objective on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Monday, December 1st. Finally, Guggenheim upped their price target on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, January 2nd. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.